Nektar Therapeutics (NASDAQ:NKTR)

10.81
BATS BZX Real-Time Price
As of 9:40am ET
 -0.19 / -1.73%
Today’s Change
10.10
Today|||52-Week Range
17.53
-30.26%
Year-to-Date

Today’s Trading

Previous close11.00
Today’s openn.a.
Day’s range-- - --
Volume31,734
Average volume (3 months)1,240,033
Market cap$1.4B
Dividend yield--
Data as of 03/31/2015

Growth & Valuation

Earnings growth (last year)+70.00%
Earnings growth (this year)+8.27%
Earnings growth (next 5 years)-8.06%
Revenue growth (last year)+34.77%
P/E ratioNM
Price/Sales9.80
Price/Book39.73

Competitors

 Today’s
change
Today’s
% change
ARIAARIAD Pharmaceutical...-0.14-1.70%
KERXKeryx Biopharmaceuti...-0.32-2.51%
PRAHPRA Health Sciences ...0.000.00%
NXTMNxStage Medical Inc+0.21+1.21%
Data as of 9:40am ET, 04/01/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)-$0.40
Annual revenue (last year)$200.7M
Annual profit (last year)-$53.9M
Net profit margin-26.86%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Class I Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account